{"database": "openregs", "table": "federal_register", "rows": [["2013-11005", "Draft Guidance for Industry on Expanded Access to Investigational Drugs for Treatment Use-Questions and Answers; Availability", "Proposed Rule", "The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled \"Expanded Access to Investigational Drugs for Treatment Use--Qs & As.\" This guidance is intended to provide information for industry, researchers, physicians, and patients about certain aspects of FDA's implementation of its regulations on expanded access to investigational drugs for treatment use. FDA has received a number of questions about implementation of its expanded access regulations. Therefore, FDA is providing this draft guidance in a question and answer format, addressing the most frequently asked questions.", "2013-05-09", 2013, 5, "https://www.federalregister.gov/documents/2013/05/09/2013-11005/draft-guidance-for-industry-on-expanded-access-to-investigational-drugs-for-treatment-use-questions", "https://www.govinfo.gov/content/pkg/FR-2013-05-09/pdf/2013-11005.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled \"Expanded Access to Investigational Drugs for Treatment Use--Qs & As.\" This guidance is intended to provide information for industry,...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2013-11005"], "units": {}, "query_ms": 63.39590600691736, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}